Genome and Company announces Clinical Trial…
SEOUL, South Korea, March 3, 2022 -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo!-->…
SEOUL, South Korea, March 3, 2022 -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo!-->…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.